Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare BATS:BLKC NYSEARCA:CLIA NYSEARCA:OBOR NYSEARCA:THNR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLKCInvesco Alerian Galaxy Blockchain Users and Decentralized Commerce ETF$20.63$20.63$16.21▼$33.15$3.09M2.091,950 shsN/ACLIAVeridien Climate Action ETF$18.61-0.2%$18.61$16.48▼$21.28$23.45M1.349,925 shs75,500 shsOBORKraneShares MSCI One Belt One Road Index ETF$27.92+1.3%$28.14$22.03▼$30.07$2.79M0.445,329 shs76 shsTHNRAmplify Weight Loss Drug & Treatment ETF$24.76+0.3%$24.66$20.98▼$27.28$4.21M0.42,133 shs716 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLKCInvesco Alerian Galaxy Blockchain Users and Decentralized Commerce ETF0.00%0.00%0.00%-5.21%+3.62%CLIAVeridien Climate Action ETF0.00%0.00%0.00%0.00%0.00%OBORKraneShares MSCI One Belt One Road Index ETF-0.04%+1.42%+1.53%-2.21%+26.22%THNRAmplify Weight Loss Drug & Treatment ETF+0.53%+3.55%-0.56%-4.66%+11.33%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLKCInvesco Alerian Galaxy Blockchain Users and Decentralized Commerce ETF$20.63$20.63$16.21▼$33.15$3.09M2.091,950 shsN/ACLIAVeridien Climate Action ETF$18.61-0.2%$18.61$16.48▼$21.28$23.45M1.349,925 shs75,500 shsOBORKraneShares MSCI One Belt One Road Index ETF$27.92+1.3%$28.14$22.03▼$30.07$2.79M0.445,329 shs76 shsTHNRAmplify Weight Loss Drug & Treatment ETF$24.76+0.3%$24.66$20.98▼$27.28$4.21M0.42,133 shs716 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLKCInvesco Alerian Galaxy Blockchain Users and Decentralized Commerce ETF0.00%0.00%0.00%-5.21%+3.62%CLIAVeridien Climate Action ETF0.00%0.00%0.00%0.00%0.00%OBORKraneShares MSCI One Belt One Road Index ETF-0.04%+1.42%+1.53%-2.21%+26.22%THNRAmplify Weight Loss Drug & Treatment ETF+0.53%+3.55%-0.56%-4.66%+11.33%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLKCInvesco Alerian Galaxy Blockchain Users and Decentralized Commerce ETF 2.55Moderate Buy$20.63N/ACLIAVeridien Climate Action ETF 2.47Hold$18.61N/AOBORKraneShares MSCI One Belt One Road Index ETF 1.00Strong Sell$27.92N/ATHNRAmplify Weight Loss Drug & Treatment ETF 2.60Moderate Buy$24.76N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLKCInvesco Alerian Galaxy Blockchain Users and Decentralized Commerce ETFN/AN/AN/AN/AN/AN/ACLIAVeridien Climate Action ETFN/AN/AN/AN/AN/AN/AOBORKraneShares MSCI One Belt One Road Index ETFN/AN/AN/AN/AN/AN/ATHNRAmplify Weight Loss Drug & Treatment ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLKCInvesco Alerian Galaxy Blockchain Users and Decentralized Commerce ETFN/AN/A22.75N/AN/AN/AN/AN/AN/ACLIAVeridien Climate Action ETFN/AN/A16.68N/AN/AN/AN/AN/AN/AOBORKraneShares MSCI One Belt One Road Index ETFN/AN/A11.41N/AN/AN/AN/AN/AN/ATHNRAmplify Weight Loss Drug & Treatment ETFN/AN/A24.31N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBLKCInvesco Alerian Galaxy Blockchain Users and Decentralized Commerce ETF$5.4226.27%N/AN/AN/ACLIAVeridien Climate Action ETFN/AN/AN/AN/AN/AOBORKraneShares MSCI One Belt One Road Index ETF$0.812.90%N/AN/AN/ATHNRAmplify Weight Loss Drug & Treatment ETF$0.220.89%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLKCInvesco Alerian Galaxy Blockchain Users and Decentralized Commerce ETFN/ACLIAVeridien Climate Action ETFN/AOBORKraneShares MSCI One Belt One Road Index ETFN/ATHNRAmplify Weight Loss Drug & Treatment ETFN/AInsider OwnershipCompanyInsider OwnershipBLKCInvesco Alerian Galaxy Blockchain Users and Decentralized Commerce ETFN/ACLIAVeridien Climate Action ETFN/AOBORKraneShares MSCI One Belt One Road Index ETFN/ATHNRAmplify Weight Loss Drug & Treatment ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLKCInvesco Alerian Galaxy Blockchain Users and Decentralized Commerce ETFN/A150,000N/ANot OptionableCLIAVeridien Climate Action ETFN/A1.26 millionN/ANot OptionableOBORKraneShares MSCI One Belt One Road Index ETFN/A100,000N/ANot OptionableTHNRAmplify Weight Loss Drug & Treatment ETFN/A170,000N/AN/ABLKC, THNR, CLIA, and OBOR HeadlinesRecent News About These Companies3 Ways to Invest in the Growing GLP-1 Weight Loss Market (THNR)...April 17, 2026 | marketbeat.comWeight Loss ETF THNR Reweights Its Index: What's Up & DownMarch 25, 2026 | etftrends.comEAmplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR) Short Interest UpdateMarch 13, 2026 | defenseworld.netDETFs tied to HIMS gain attention as the telehealth stock spikesMarch 9, 2026 | msn.comHealthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales OutlookFebruary 4, 2026 | zacks.comNew Year, New Strategy: Navigating Weight Loss ETFsJanuary 12, 2026 | etftrends.comEHims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFsSeptember 18, 2025 | benzinga.comWeight Loss Drug ETF (THNR) Hits New 52-Week HighJune 2, 2025 | zacks.comNew Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFsJanuary 17, 2025 | etftrends.comEDisruptive Theme of the Week – Breakthroughs in MedicineNovember 21, 2024 | etftrends.comEAmplify ETFs Hits $10 Billion in Assets Amid New ETF LaunchesOctober 29, 2024 | etftrends.comETap the Weight-Loss Drug Market With These ETFsSeptember 18, 2024 | zacks.comDisruptive Theme of the Week: Playing DefenseAugust 14, 2024 | etftrends.comEETFs in Focus as Competition Heats Up in Weight Loss Drug SegmentJuly 22, 2024 | zacks.comTop Themes in the First Half of 2024: Crypto, Chips, Ships & SilverJuly 2, 2024 | etftrends.comEWhy Investors Haven't Feasted on Two New Weight-Loss ETFsJune 24, 2024 | investopedia.comFinding Opportunity in Unloved Healthcare ETFsMay 31, 2024 | etftrends.comEPlay These New ETFs to Tap Lucrative Weight Loss Drug MarketMay 22, 2024 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesWith Nike Shares Near a 12-Year Low, Is Now the Time to Be Brave?By Sam Quirke | April 12, 20263 Dividend Aristocrats Whose Yields Can Help Combat InflationBy Chris Markoch | April 9, 2026The War Won't Last Forever: 3 Stocks That Could Lead the RecoveryBy Bridget Bennett | April 8, 20263 Discounted Stocks With Strong Rebound PotentialBy Chris Markoch | April 6, 20263 Ways to Invest in the Growing GLP-1 Weight Loss MarketBy Nathan Reiff | April 17, 2026BLKC, THNR, CLIA, and OBOR Company DescriptionsInvesco Alerian Galaxy Blockchain Users and Decentralized Commerce ETF BATS:BLKC$20.63 0.00 (0.00%) As of 02/25/2026The Invesco Alerian Galaxy Blockchain Users and Decentralized Commerce ETF (BLKC) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The investment objective of this Fund is to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NYSE FactSet Global Blockchain Technologies Capped Index. BLKC was launched on Oct 7, 2021 and is managed by BlackRock.Veridien Climate Action ETF NYSEARCA:CLIA$18.61 -0.04 (-0.21%) As of 08/16/2024The Veridien Climate Action ETF (CLIA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed, non-transparent ETF that seeks to invest in companies, via US-listed stocks or ADRs from around the world, that are considered to be making a substantial contribution to mitigating climate change. The fund utilizes the Precidian non-transparent model CLIA was launched on May 8, 2023 and is managed by Veridien.KraneShares MSCI One Belt One Road Index ETF NYSEARCA:OBOR$27.92 +0.37 (+1.34%) As of 05/5/2026 04:10 PM EasternThe KraneShares MSCI One Belt One Road Index ETF (OBOR) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected, tier-weighted index of companies likely to benefit from China's One Belt, One Road initiative. OBOR was launched on Sep 7, 2017 and is managed by KraneShares.Amplify Weight Loss Drug & Treatment ETF NYSEARCA:THNR$24.76 +0.08 (+0.32%) As of 05/5/2026 04:10 PM EasternThe Amplify Weight Loss Drug & Treatment ETF (THNR) is an exchange-traded fund that is based on the VettaFi Weight Loss Drug index. The fund tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses. THNR was launched on May 21, 2024 and is issued by Amplify Investments. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Drops After a Blowout Q1—What Investors Should Know Shopify’s Valuation Crisis Creates Opportunity in 2026 onsemi Stock Dips After Earnings: Why the Dip Is Buyable TSLA: 3 Reasons the Stock Could Hit $400 in May Nebius Breaks Out to All-Time Highs—Here's What's Driving It. 3 Reasons Analysts Love DexCom The Great Chip Divide: AI Chip War Pivots from Hype to Execution Atomic Dividends: Big Tech's New Energy Bet Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
